<html>
<head>PUBMED IDs for GCNT1</head>
<body bgcolor='#C5F0F2'><h1>GCNT1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/22454501/'>Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity.</a> July 13  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24753248/'>Determination of carbohydrate structure recognized by prostate-specific F77 monoclonal antibody through expression analysis of glycosyltransferase genes.</a> October 8  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24854630/'>Increased expression of GCNT1 is associated with altered O-glycosylation of PSA, PAP, and MUC1 in human prostate cancers.</a> July 30  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26452038/'>The androgen receptor controls expression of the cancer-associated sTn antigen and cell adhesion through induction of ST6GalNAc1 in prostate cancer.</a> August 16  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26883286/'>Discovery of candidate tumor biomarkers for treatment with intraperitoneal chemotherapy for ovarian cancer.</a> January 4  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27340696/'>Comparison of the Gene Coding Contents and Other Unusual Features of the GC-Rich and AT-Rich Branch Probosciviruses.</a> June 25  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27428423/'>Glycosylation is an Androgen-Regulated Process Essential for Prostate Cancer Cell Viability.</a> February 15  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27730440/'>Recent progress and perspectives on prostate cancer biomarkers.</a> October 13  2016<br></body></html>
